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Abstract 
Background: The assessment of Micronuclei frequency in exfoliated oral 
epithelial cells have been shown to correlate with severity of the genotoxic damage 
and seem to increase steadily in order from tobacco chewers with apparently 
normal mucosa to premalignant and malignant lesions.  
Aim: To evaluate the frequency of micronuclei (MN) in oral exfoliated cells of 
tobacco chewers with oral premalignant and malignant lesions and comparing 
them with that of healthy tobacco chewers and controls of non tobacco chewers. 
Materials and Methods : The study subjects are divided into four groups 
consisting of tobacco chewers with apparently healthy oral mucosa, premalignant 
lesions and malignancy, and normal controls, each of 20 cases. The cytosmears are 
stained with Pap, Giemsa and Crystal violet stains. The micronuclei was identified 
using Tolbert’s criteria.   
Results: The frequency of micronuclei is found to be higher in malignant lesions 
as compared with premalignant lesions and healthy tobacco chewers, and controls  
Conclusions: Hence, micronuclei can be used as a biomarker of genotoxic 
damage, which is an useful diagnostic as well as prognostic indicator. 
Keywords: Micronuclei, oral exfoliative cytology, tobacco chewers, squamous 
cell carcinoma, premalignant lesions, Papanicolaou, Giemsa, Crystal violet stains. 
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INTRODUCTION 
          Cancer is one among the most important and common cause 
of mortality and morbidity worldwide. Oral cancer is one among the 10 
most commonly occuring cancers as stated by World Health Organization 
(WHO) and annually 5, 75, 000 new cases are detected and  about          
3, 20, 000 deaths occur worldwide.1 Oral cancer is of the emerging trends 
because of behavior and lifestyle modifications mainly smoking and 
smokeless forms of tobacco. 
Oral squamous cell carcinoma has poor prognosis with an 
overall median survival rate of 56%2, and the poor prognosis is mainly 
accounted by the late diagnosis and treatment owing to the ignorance of 
the patients. Hence early diagnosis and treatment is the key to reduce 
morbidity and improve the survival rate.  
Though oral cancers are easy to detect and histopathology of 
tissue biopsy remains the gold standard diagnostic tool, it is the need of 
the hour to implement new screening modalities using biomarkers to 
detect high risk cases. One such biomarker is micronuclei assay in 
exfoliative cytology of buccal smears, which can be used as a diagnostic 
as well as prognostic indicator. 
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                     Micronuclei are extranuclear cytoplasmic bodies seen in 
association with chromosomal aberrations. They are induced by many 
substances like alcohol, tobacco, betal nut and irradiation. Hence the 
micronuclei assessment in exfoliated buccal cells will turn to be a 
promising tool in the study of epithelial damage and to detect the 
pathogenesis of carcinoma in relation to chromosomal breakage or 
mitotic interference. 
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AIMS AND OBJECTIVES 
1. To evaluate the micronuclei frequencies in oral exfoliated cells of 
tobacco chewers with oral preneoplastic and neoplastic lesions and 
comparing with tobacco chewers of apparently healthy oral 
mucosa.   
2. Comparison of micronuclei frequencies among nontobacco users 
and tobacco chewers, who are at high risk of developing oral 
cancer. 
3. Comparison of micronuclei in oral exfoliated cells using various 
staining procedures like Papanicolaou, Giemsa and Crystal violet 
stains.  
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                        REVIEW OF LITERATURE 
INTRODUCTION: 
                            Oral carcinoma globally has the age standardized 
incidence of 2.1% , with 2.7% in males and 1.3% in females. The 
mortality is 1.8% worldwide, constituting about 2.1% in males and 1.3% 
in females. Oral cancer is one of the top three cancers in India accounting 
for 30% of all cancers.1 India is said to be the oral cancer capital of the 
world. In India, about 90% of the oral cancers are related to tobacco use. 
The World Health Organization (WHO) has calculated the rise of 
mortality due to tobacco related diseases in India from 1.4% in 1990 to 
13.3% in 2020.(1,2) About half of all cases of oral cancer have associated 
leukoplakia. Other premalignant lesions and conditions are submucous 
fibrosis, erythroplakia, lichen planus, and chronic immunosuppression. 3 
                                   At present, the most reliable way to control and reduce 
oral cancer is to merge early diagnosis with timely and appropriate 
treatment. As more than 90% of all oral neoplasms are squamous cell 
carcinomas, almost all of them are diagnosed from lesions on the mucosal 
surfaces. Hence oral exfoliative cytology has become a promising tool in 
early diagnosis of high risk individuals of oral cancer.  
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                 Oral cavity is the entrance of the gastrointestinal tract. It begins 
with the lips in the anterior and ends with the oropharynx.  
The main functions are 
              i) it serves as one of the protective barrier of the body  
             ii )  gives taste sensation 
             iii) provides lubrication through saliva and aids in swallowing 
             iv) provides immunological defense mechanism              
              v) speech  
             vi) initiates digestion 
ANATOMY: 
                                   The oral cavity is classified anatomically into three 
parts - the vestibule, oral cavity proper and the last is the oropharynx. The 
vestibule is the space occupied medially by teeth and laterally by the lips 
in the front and cheeks sideways. The oral cavity proper lies within the 
dental arches and is bounded by the palatoglossal arch posteriorly. 
Posterior to the palatoglossal arch, lies the oropharynx.  The posterior 
one-third of the tongue, soft palate, palatine tonsils and posterior wall 
constitutes the oropharynx. The palatine tonsils lie between the 
palatoglossal arch anteriorly and palatopharyngeal arches posteriorly. The 
retromolar trigone is a triangular area which lies behind the last molar 
teeth and represents the posterior part of the vestibule of the mouth. 
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                             Based on the topography of the oral lesions, the oral 
cavity is divided into various regions as follows 1) Lip, 2) Buccal 
mucosa, 3) Tongue,  4) Hard palate,  5) Gingiva, 6) Floor of the mouth, 7) 
Soft palate, 8) Retromolar trigone,  9)Base of the tongue,  10) Tonsillar 
area and 11) Pharyngeal wall.4 
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HISTOLOGY:  
                        Oral cavity has an overlying thicker epithelium compared 
to that of skin. The muscle is superficial in tongue and deep in case of 
buccal and labial mucosa. The minor salivary glands are mostly mucous, 
although serous acini are also seen throughout the oral cavity except in 
gingiva and tongue. 
                        The oral mucosa is subdivided into three groups based on 
the lining epithelium, connective tissue structures and its functions  
  i) Lining mucosa 
ii) Masticatory mucosa 
iii) Specialized mucosa 
I. Lining mucosa – forms the inner surface of the buccal mucosa, soft 
palate, floor of the mouth, lips and inferior surface of the tongue. 
                        Buccal mucosa has nonkeratinized stratified squamous 
epithelium, 15 – 20 cells thick with broad tapered rete ridges, loose 
fibrovascular tissue in lamina propia and muscle at the base. Perinuclear 
halo may be seen because of glycogen. 
                           Soft palate and floor of mouth have thin stratified     
squamous epithelium, 10 – 15 cells thick with poorly formed rete ridges. 
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Ventral tongue has serous salivary gland   (anterior – glands of Blandin & 
Nuhn and posterior – glands of Von Ebner). 
II. Masticatory mucosa – covers the gingiva and hard palate 
                      Hard palate shows keratinized stratified squamous 
epithelium, thin layer of orthokeratin with thin granular layer and are 15 -
20 cells thick. It has dense lamina propria, fatty tissue with neurovascular 
bundles and minor salivary glands and at the base, the periosteum. There 
is no submucosa. 
   Gingiva share similar histological fingings with hard palate, 
but with more slender and tapered rete ridges. Rests of odontogenic 
epithelium ( rests of Serres) with abundant clear cells are also seen. 
III. Specialized mucosa (tongue): 
                     Tongue is lined by keratinized stratified squamous 
epithelium with thick parakeratin layer, 20 – 30 cells thick and skeletal 
muscle seen superficially. Filiform papillae are keratotic spires and have 
surrounding bacterial colonies. They have no taste buds. Fungiform 
papillae (taste buds in apical surface), circumvalate and foliate papillae    
(lateral wall) have fibrovascular polypoid structure with taste buds. 
Lingual tonsils are seen in lateral tongue and posterior dorsum.5,6 
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 CYTOLOGY:          
 Buccal cells are the first and foremost barrier for both of 
inhalation and ingestion route.  They serve as preferred sites and target 
for early genotoxic events induced by carcinogenic agents. The oral 
epithelium is capable of continuous renewal of cells. Hence new cells 
formed in the basal layer by mitosis, upon time migrate to the surface and 
replace the shed cells. The stem cells expressing genetic damage are 
present in the basal layer. The cells formed will differentiate into the 
keratinized superficial layer and are exfoliated into the buccal cavity. The 
biomarkers of genomic damage like micronuclei, nuclear buds and those 
of cell death like apoptosis and karyolysis are identified in both the 
lymphocyte and buccal cells. Thus micronuclei assay is a newer novel 
technique in oral exfoliative cytology.7 
 Micronucleus in oral exfoliated cells is a marker of 
chromosomal damage caused by genotoxic agents from tobacco and 
tobacco-related substances, radiation and alcohol.8 The micronucleus 
assay has been used to assess the genotoxic damage in oral squamous cell 
carcinoma and premalignant lesions.9,10 The MN assay has been reported 
to  correlate well  with  leukoplakia and the  histological  grading  of  oral  
squamous cell carcinoma.  Incidence of micronuclei has been analyzed by 
various studies in oral premalignant lesions, squamous cell carcinomas 
and normal patients.11-4  
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HISTORICAL HIGHLIGHTS OF MICRONUCLEUS: 
Micronuclei assay has been used as an indicator of genotoxic 
exposure since 1937, based on the radiation studies conducted by 
Brennecke and Mather.15  In 1900s, Howell and Jolly found few nuclear 
remnants in human reticulocytes , that are Feulgen-positive and named 
after them as Howell-Jolly bodies. These nuclear bodies represent 
chromosomes separated from the mitotic spindle .16 The term 
micronucleus test was first introduced in early 1970s, by Boller and 
Schmidt and Heddle who ascertained that this assay proves to be a 
simple method to detect the genotoxic potential of mutagens after in vivo 
exposure of animals using bone marrow erythrocytes. A few years later 
in 1976, Countryman and Heddle established micronucleus approach 
in peripheral blood lymphocytes and they recommended micronuclei 
assay as a biomarker in testing schemes.17 
                       Stich et al is the first to develop a protocol for 
micronucleus assay in exfoliated buccal mucosa cells in1983.(14-22) It was 
used widely in occupational and lifestyle studies. Many studies have been 
published in the past 25 years using micronucleus assay in epithelial cells 
from oral mucosa, nasal mucosa, cervix, bronchus, bladder and 
oesophagus. 
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The Human Micronucleus (HUMN) project was established 
in 1997. This was an international collaborative program aimed to 
standardize micronucleus assay in peripheral blood lymphocytes and to 
assess the effects of protocol and scoring criteria on the values obtained. 
HUMN project published the results in 2001.23-4 
MICRONUCLEUS : 
Micronucleus is an erratic nucleus which is formed during 
the anaphase of mitosis or meiosis. Micronuclei are globular cytoplasmic 
bodies containing a portion of acentric chromosome or entire 
chromosome which fails to move to the opposite poles during anaphase. 
This results in the daughter cell that lacks a part or all of a chromosome. 
These chromosome fragments or entire chromosomes develop nuclear 
membranes and transform as micronuclei. After cytokinesis, one 
daughter cell ends up with one nucleus and the other ends up with one 
large and one small nucleus, i.e., micronucleus.  
More than one micronucleus can be formed in case of more 
genetic damage. They are usually formed in the basal cells of epidermis. 
These cells are shed as exfoliated cells on maturation.  Hence 
micronuclei assay can be used as one of the biomarkers of oral cancer, as  
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it is increased in oral preneoplastic and neoplastic conditions. 
Micronucleus can be identified by various special stains in exfoliative 
cytology.19,21 
The pattern of formation of micronucleus in an individual 
depends on the type and amount of carcinogen exposure. The pattern 
produced by single and short term exposure will be different from those 
causing uniform and chronic exposure. The micronuclei frequency also 
seems to decrease with time, as this chromosomal damage can lead to 
apoptosis of the cell or loss of micronucleus during cell division.  
The micronuclei can be demonstrated in erythrocytes, 
lymphocytes and exfoliated cells like oral, nasal and urothelial cells.  
Here, MN assay is used to evaluate the genomic damage occurred in 
vivo. Hence, the assay is employed in the analysis of cancers occurring 
in oral cavity, nasal cavity, bronchi, cervix, oesophagus, bladder and 
urinary tract. 25-6  
Micronucleus in a cell can be identified by many staining 
techniques. These include DNA specific stains like Fuelgen, acridine 
orange and 4’,6-diaminido-2-phenylindole (DAPI) . The other non  
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specific stains are Giemsa, May Grunwald Giemsa, propidium iodide, 
Papanicolaou and crystal violet stains. Of these, DNA specific Fuelgen 
method is preferred by many laboratories.27-8 Micronucleus assay  is also  
done by using FISH (Fluorescence in situ hybridization) with a 
centromeric probe  and  micronucleus is seen as bright yellow green 
spots. FISH has the advantage of differentiating the mode of formation 
of micronuclei (clastogenic / aneuploidogenic mechanism).29 
Micronucleus assay has been used to analyse chromosomal 
damage caused by various mutagenic and carcinogenic chemicals and 
many physical agents. These are mainly occupational hazards, lifestyle 
modification factors and irradiation. Some of the causative agents 
include all forms of tobacco, areca nut usage, alcohol, antineoplastic 
drugs, arsenic in drinking water, dioxin as fertilizers, pesticide mixtures, 
polycyclic aromatic hydrocarbons, ethylene oxide, formaldehyde, 
chlorants, toxic gases, lead oxide, solvents, toluene, benzene, ozone, 
acetone, hexane, 2-trans hexol and methl-ethyl ketone.30-8 
Kamboj and Mahajan point out that assessment of 
micronuclei in buccal mucosa epithelial cells is a valuable biomarker for 
early detection of premalignant and malignant lesions of various sites.39 
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GENOTOXIC DAMAGE: 
Genomic damage is the most important basic cause of 
degenerative and developmental diseases. It has been well established 
that genomic damage is caused by  inherited genetic factors like defects 
in DNA metabolism and repair, environmental exposure to genotoxins, 
radiation , chemicals, micronutrients deficiency like folate and lifestyle 
factors (eg, smoking, alcohol, tobacco use, stress and drugs).29,31-40  
The role of carcinogen is to induce chromosomal instabilities 
like deletions, translocations, gain or loss of the whole chromosomes, 
leading to the development of malignant cellular alterations .40 So it has 
become essential to introduce reliable and relevant minimally invasive 
biomarkers. This will help in the implementation of diagnosis, 
monitoring, and treatment of diseases caused by, or associated with, 
genetic damage. One such valuable marker is micronuclei assay in 
exfoliative oral cytology. 
The pathogenesis of genotoxic damage and the consequences 
are stated in the following diagram                     
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                                PATHOGENESIS 
 
 
 
 
 
 
 
 
 
EPIDEMIOLOGY OF ORAL CANCERS: 
Oral cancer is the sixth common malignancy in the world. 
Annually about 5,00,000 new cases of oral cancers are diagnosed , of 
which three fourth of them occur in developing countries. The highest 
incidence is seen in France and also in Switzerland, Italy, Hungary and 
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Latin America. In India, about 75,000 to 80,000 cases are reported 
annually. In India, the age adjusted incidence rate of oral cancer is 20 per 
100,000 which is very high and the overall incidence among all cancers 
is 30%. The oral cancer is mainly concentrated in the SEAR (South East 
Asian region) where the smokers and smokeless tobacco users are 
distributed equally, each constituting for about 250 million people. In 
India, tobacco chewers are about 26% and smokers are 14%. About 65% 
of the overall cancer cases are related to tobacco usage in India. 
Annually, tobacco alone contributes to 1,50,000 cancer cases, 42,00,000 
heart diseases and 37,00,000 lung diseases in India. Cancer deaths in 
India is estimated to be around 56,00,000 /yr , of which tobacco is 
responsible for one third of the cases, with 2500 deaths/day contributed 
by tobacco related diseases. Global mortality of tobacco related diseases 
is said to be 22% per year. 
                      Oral cancers have a higher incidence in men than in 
women. The male to female ratio is 3:1. The incidence of oral cancer in 
India is observed to be around 6.9% in males and 2.4% in females. This is 
probably because of risk factors like smoking, alcohol and chewing pan.  
In India, highest rates are observed in women who are heavy tobacco 
chewers. The mortality rate in males is 2.3% whereas in females it is 
0.6%.  
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                     Oral carcinoma is commonly seen over the age of 50 years.  
Compared to the U.S population, the incidence is higher in India. In U.S., 
oral malignancies amount to only 3% of all cancers with age adjusted 
incidence being 10 per 100,000 as against India with 30% of all cancers 
and higher incidence. The difference is mainly due to increased chance of 
risk factors and race. 
 The Government of India spends about one fourth of the 
health expenditure ie. around Rs.300 billion annually for the treatment of  
tobacco associated illness.2,41-50 
About 90% of the oral cancers are squamous cell 
carcinoma51. These tumors arise in any of the intraoral sites. Lip cancer 
constitutes about 20 – 40%. Intraorally, tongue is the most common site 
for SCC amounting to 25 – 40%, then is the soft palate complex, and less 
common are the buccal mucosa and floor of the mouth with 10 – 20%. 
But the incidence of buccal mucosal tumours seems to be higher in case 
of tobacco chewers. 
  ETIOPATHOGENESIS: 
There are a number of known risk factors for oral squamous 
cell carcinoma. Some of the lifestyle factors are smoking, alcohol, and 
diet, mainly vitamin deficiencies and supplementation.14,20,52 Most of the 
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studies with a significant increase in MN are related to a risk of oral 
cancer. They are performed in subgroups of subjects with specific 
lifestyle habits like chewers of betel quids (areca nut, betel leaves, slaked 
lime, and tobacco), snuff dippers, Khaini tobacco users (tobacco with 
slaked lime), reverse smokers, etc. 26,53-6 Results  showed a rise in the 
micronuclei  frequency because both smoking and chewing of tobacco 
mixtures cause nuclear degeneration, and in addition, the appearance of 
MN-like bodies in exfoliated cells are likely to be confused with 
micronulei. So, it is important to distinguish cell death events from 
genome damage in viable epithelial cells in evaluating cancer risk. 
TOBACCO: 
The major risk factor for oral squamous cell carcinoma is all 
forms of tobacco. Many carcinogens have been identified in tobacco and 
its combustion products. The most important agents are polycyclic 
aromatic hydrocarbons containing benzene, tobacco-specific aromatic 
amines and nitrosamines. These compounds cause epithelial damage in a 
dose-dependent manner.  Comparitively, Smokeless tobacco results in 
disruption of DNA repair mechanisms and harmful genetic mutations 
which will finally lead to malignant transformation.  
Smokers have an increased risk which is about five- to ten-
fold risk of developing oral cancer, as is also the case with Cigar and pipe 
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smokers. Smokeless tobacco has a lower risk of oral cancer than smoked 
tobacco. Risk depends on the composition of the particular product used 
and can even rise to fourfold higher than that of a non-user. The habit of 
chewing coarsely cut tobacco leaves (chewing tobacco) or holding finely 
ground tobacco leaves (snuff) in the mandibular vestibule is common 
among certain populations around the world, most notably in India and 
Southeast Asia. Either habit is referred to as smokeless tobacco use or spit 
tobacco use. The habit is usually started early in life, at 8 to 14 years of 
age. 
 It has been estimated that the usage of tobacco in any form 
among the people of 15 to 49 years of age is said to be 57% in men and 
11% in women. Several health and addiction hazards may be associated 
with the use of spit tobacco because of the ready absorption of nicotine 
and other molecules through the oral mucosa. The theory is that tobacco-
specific nitrosamines induce dysplastic changes in the epithelium and 
these changes are probably intensified with prolonged surface contact.53-60 
FORMS OF SMOKELESS TOBACCO: 
There are many forms of tobacco which are mostly 
homemade or manufactured commercially. Some of them are as follows 
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    Tobacco products 
1. Paan with tobacco 
 
2. Paan masala 
 
3. Manipuri tobacco 
 
 4.Mawa 
 
5. Khaini 
 
6. Snus 
Ingredients 
Betal leaf, areca nut, slaked lime, catechu, tobacco, 
condiments with sweetening agents. 
Similar to pan, the contents are dehydrated. This is  
prepared commercially 
Tobacco, finely cut areca nut, camphor, slaked lime and 
cloves. It is used in Manipuri district of Uttar Pradesh. 
Scrapings of areca nut, some tobacco and slaked lime. It is 
used in Gujarat.   
Combination of sun dried tobacco and slaked lime.  
It is used mostly in Maharastra and North India. 
Snuff prepared in the form of tea bag like pouch, which      
is sucked by placing in buccal  mucosa. It is marketed as  
‘click’ (Swedish company) 
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Tobacco is also used in many dental care products and some 
advertise tobacco as a means of cleaning teeth. It indirectly causes 
addiction on regular usage, leading to increased ill effects of tobacco.  
Few of the marketed products are Mishri, Bajjar, Gul, 
Gudhaku, Lal Dantamanjan, creamy snuff and tobacco water.61 
 ALCOHOL: 
Alcohol consumption poses an important risk for oral cancer 
in “moderate to heavy” drinkers (five to eight drinks per day). Alcohol 
and tobacco have a synergistic effect, enhancing the effect of each other. 
Ethanol alters the permeability of the oral mucosa, by acting locally, to 
various substances like carcinogens and hence enhances their penetration 
into the tissues. Alcoholic beverages also cause decreased cell 
metabolism systemically, thereby leading to relative immune 
deficiency.62-3 
BETEL: 
 Betel products, which are derived from the nut of the areca 
palm, prove to be potential carcinogens. They are used commonly in 
Southeast Asia and the Indian subcontinent. Preparations usually consist 
of a mixture of betel leaf, tobacco, betel nut and slaked lime (calcium 
hydroxide). Addition of lime potentiates carcinogenicity besides giving 
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an euphoric effect. Prolonged usage may lead to the development of 
submucous fibrosis. 
Gutkha and pan masala are in more demand among all age 
groups. Betel quid chewing with or without tobacco is claimed to be 
carcinogenic in humans. Gutkha is the mixture of areca nut and tobacco 
with addition of catechu, cardamom, lime, spices and flavouring agents. 
Gutkha is found to be responsible for a number of oral diseases and has 
addictive effects that lead to the addiction due to the presence of areca 
nut and tobacco. 61,64 
VIRAL INFECTIONS: 
  Viruses also play a role in certain benign and malignant 
neoplasms of the head and neck.  Epstein-Barr Virus (EBV) is related to 
nasopharyngeal carcinoma, Burkitt lymphoma, and other lymphomas. 
Human herpesvirus virus 8(HHV-8) is associated with Kaposi sarcoma in 
immunocompromised and HIV-infectedpatients. Human papillomavirus 
(HPV) has been well established to cause benign proliferative epithelial 
lesions like squamous papilloma and condylomata throughout the head 
and neck region and malignant tumors of the posterior oral cavity and 
oropharynx. The exact etiology of viral involvement is still under 
research.65-7 
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 IMMUNOSUPPRESSION: 
Immunosuppressed individuals have high risk for 
malignancy throughout the body, as also in oral cavity. HIV-infected 
patients are prone to develop Non-Hodgkin lymphoma, Kaposi sarcoma 
and oral Squamous cell carcinoma. Similarly, transplant patients are 
associated with increased risk for multiple oral malignancies .Inherited  
disorders like dyskeratosis congenita,  associated with progressive bone 
marrow failure causing aplastic anemia and presents with skin 
hyperpigmentation, dystrophic nail changes and leukoplakia which has 
increased risk of malignant transformation. Yet another rare bone 
marrow failure syndrome Fanconi anemia is also associated with high 
risk for oral Squamous cell carcinoma.62,68 
NUTRITION: 
 Nutritional factors such as β carotene, vitamin A, retinol,      
α tocopherol, zinc, riboflavin, selenium and Chinese tea have been proved 
to be protective against oral cancers. Hence   vitamin and mineral 
deficiencies may lead to carcinogenesis, though no specific pathogenetic 
mechanism has been elicited. This may possibly be related to loss of 
antioxidant mechanism leading to the formation of free radicals. One 
such example is Plummer–Vinson syndrome, rare condition presenting in 
middle-aged women, with dysphagia, esophageal webs, and iron 
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deficiency anemia and is thought to be at increased risk for oral and 
esophageal carcinoma.62,68 
SANGUINARIA: 
Extract derived from Sanguinaria canadensis, a common 
bloodroot plant has been commercially used as an antibacterial agent in 
oral rinses and toothpaste as to reduce plaque and gingivitis. It has been 
said to be associated with the development of leukoplakia particularly in 
the maxillary vestibule. But malignant transformation in these lesions is 
not established.69  
MOLECULAR GENETICS: 
The common genetic alterations seen in oral squamous cell 
carcinoma are mutations involving p16, p53, cyclin D1, p63, PTEN , Rb , 
and epidermal growth factor receptor (EGFR).  p16 mutations are seen in 
80% of oral cancers. The critical pathways involve mainly p53 
inactivation by mutation and inhibition of HPV-16 E6 protein, EGFR  
overexpression and activation of signal transducer and activator of 
transcription 3 (STAT3) and vascular endothelial growth factor receptor 
(VEGFR).  Carcinogens in tobacco cause increased TP53 mutations. For 
oropharyngeal cancer, HPV is the major causative agent with more than 
50% showing HPV DNA. HPV – E6 protein inactivates p53, whereas E7 
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protein by inactivation of Rb gene lead to overexpression of p16. Gene 
expression profile identifies transcriptional signatures which help in 
predicting the overall survival and likelihood of nodal metastasis. 
Carcinogenic agents in cigarette smoke and tobacco products 
are mainly benzopyrene and nitrosamines, and same as are aresoline in 
areca nut. These products cause alteration in genes mainly in 3p, 9p and 
17.70-5 
HIGH-RISK SITES 
1. BUCCAL MUCOSA: 
Buccal mucosa is the most common location for oral 
carcinoma among tobacco users . This is probably due to the betal or 
tobacco quid which has been kept for quite long time in the mandibular 
vestibule. This further causes readily absorption of the carcinogenic 
agents and predisposes to cancer. 
2. TONGUE: 
The tongue is the next common location for oral cancer with 
more than half of lesions presenting on the oral tongue, and the rest 
occurring in the tongue base. In the oral cavity proper, lesions are most 
commonly seen on the lateral and ventral surfaces, and these areas 
remain to be the high-risk sites. Tongue base tumours seem to be more 
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advanced at the time of diagnosis, mostly presenting with metastasis to 
regional lymph nodes.  
3. LIP : 
The vermillion of the lip is another site for oral cancer, but 
the incidence is low. Most of the labial carcinomas occur on the lower 
lip, more common in men than women. Ultraviolet radiation exposure is 
the major risk factor. It may also occur in pipe smokers where the 
pipestem frequently contacts the lip for quite a long period of time. 
Usually lip cancers are diagnosed early due to its easy visibility.62,70,72 
 
INVESTIGATIONS: 
 The investigatory modalities commonly used in diagnosis of 
oral cancers are  
1. Tissue biopsy and histopathological examination, assisted with or 
without immunohistochemistry. 
2. Exfoliative cytological analysis 
Most of the malignancies develop in the setting of 
precancerous lesions. Precancerous and cancerous oral lesions can mimic 
a number of benign oral lesions which appear as a white or red lesion 
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(leukoplakia and erythroplakia). The malignant potential of these lesions 
is generally assessed by histopathology based on the presence and the 
degree of dysplasia in biopsy material. The lesions are graded as mild, 
moderate, and severe .Till now, tissue biopsy and subsequent histological 
examination remains the gold standard for the diagnosis of premalignant 
and malignant oral diseases. Oral tissue biopsy is an invasive procedure 
and involves both psychological implications for the patient and technical 
difficulties for the health practitioner. Extensive lesions may lead to 
sampling error. Moreover, there will be inter-observer variation in 
diagnosing dysplasia and reproducibility in morphological features of low 
grade dysplasia is poor. 
Compared to tissue biopsy, oral cytology technique is simple, 
noninvasive, relatively painless, and tolerated well by patients. It can be 
used for diagnosis, identification of recurrence after treatment and also 
as a prognostic marker following therapy. Moreover, it is also used for 
mass screening and is reported faster within short duration. The basic 
requirements for a useful diagnostic technique are as follows  
                        a) easy to use 
                        b) minimal patient discomfort  
                        c) adequate sampling 
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 Ideally, a diagnostic procedure should have the following requisites 
                       i) should not be complicated or time consuming 
                      ii) should have high sensitivity 
                     iii) should have the potential for automation.  
The disadvantages are sampling error, inter observer variation and 
inability to do immunohistochemistry. The sampling error is mainly due 
to topography and increased size of the oral cavity causing difficulty in 
evaluating the whole area.76 
 The exfoliative cytology not only demonstrates increased 
micronuclei frequency, but also many nuclear abnormalities. The 
common nuclear anomalies noted are as follows 
1. Increase in number of binucleated cells indicates failure of 
cytokinesis. The chromosomal non disjunction is increased in 
binucleated cells.77 
2. Cells with nuclear buds or Broken Eggs (BEN)  are indicative of 
elimination of nuclear material by budding. This may be probably 
related to DNA repair or elimination of amplified DNA.78-9 
3. Karyolysis is nuclear dissolution. The basophilia will fade due to 
enzymatic digestion of the nucleus by endonucleases. 
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4. Pyknosis is nuclear shrinkage and has increased basophilia. This 
may be a mechanism of nuclear disintegration. 
5. Karyorrhexis is nuclear fragmentation with loss of integrity. The 
nuclei have increased chromatin aggregation and speckled nuclear 
pattern. 
6. Condensed chromatin shows intense basophilia due to aggregated 
chromatin and has striated nuclear pattern. 
 
 WHO classification of tumours of the oral cavity and oropharynx 
 
Malignant epithelial tumours 
Squamous cell carcinoma 8070/3 
Verrucous carcinoma 8051/3 
Basaloid squamous cell carcinoma 8083/3 
Papillary squamous cell carcinoma 8052/3 
Spindle cell carcinoma 8074/3 
Acantholytic squamous cell carcinoma 8075/3 
Adenosquamous carcinoma 8560/3 
Carcinoma cuniculatum 8051/3 
Lymphoepithelial carcinoma 8082/3 
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Epithelial precursor lesions 
Squamous cell hyperplasia  
Mild dysplasia 
Moderate dysplasia  
Severe dysplasia  
Carcinoma in-situ  
 
Benign epithelial tumours 
Papillomas 8050/0 
Squamous cell papilloma and verruca vulgaris 
Condyloma acuminatum 
Focal epithelial hyperplasia 
Granular cell tumour 9580/0 
Keratoacanthoma 8071/1 
 
Salivary gland tumours 
Salivary gland carcinomas 
Acinic cell carcinoma 8550/3 
Mucoepidermoid carcinoma 8430/3 
Adenoid cystic carcinoma 8200/3 
Polymorphous low-grade adenocarcinoma 8525/3 
Basal cell adenocarcinoma 8147/3 
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Epithelial-myoepithelial carcinoma 8562/3 
Clear cell carcinoma, not otherwise specified 8310/3 
Cystadenocarcinoma 8450/3 
Mucinous adenocarcinoma 8480/3 
Oncocytic carcinoma 8290/3 
Salivary duct carcinoma 8500/3 
Myoepithelial carcinoma 8982/3 
Carcinoma ex pleomorphic adenoma 8941/3 
Salivary gland adenomas 
Pleomorphic adenoma 8940/0 
Myoepithelioma 8982/0 
Basal cell adenoma 8147/0 
Canalicular adenoma 8149/0 
Duct papilloma 8503/0 
Cystadenoma 8440/0 
Soft tissue tumours 
Kaposi sarcoma 9140/3 
Lymphangioma 9170/0 
Ectomesenchymal chondromyxoid tumour 
Focal oral mucinosis 
Congenital granular cell epulis 
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Haematolymphoid tumours 
Diffuse large B-cell lymphoma (DLBCL) 9680/3 
Mantle cell lymphoma 9673/3 
Follicular lymphoma 9690/3 
Extranodal marginal zone B-cell lymphoma of MALT type 9699/3 
Burkitt lymphoma 9687/3 
T-cell lymphoma (including anaplastic large cell lymphoma 9714/3 
Extramedullary plasmacytoma 9734/3 
Langerhans cell histiocytosis 9751/1 
Extramedullary myeloid sarcoma 9930/3 
Follicular dendritic cell sarcoma / tumour 9758/3 
 
Mucosal malignant melanoma 8720/3 
 
Secondary tumours80 
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PREMALIGNANT LESIONS: 
 WHO distinguishes between oral precancerous lesions and 
oral precancerous conditions.  
A precancerous lesion is defined by morphologically altered tissue that 
is more likely to be transformed into cancer than its normal counterpart, 
such as leukoplakia, erythroplakia, and the palatal changes associated 
with reverse smoking of cigarettes. 
 A precancerous condition is a state associated with a significantly 
increased risk for cancer, such as syphilis, sideropenic dysphagia, and 
oral submucous fibrosis. 
Premalignant lesions are classified by many schemes as follows80 
 
 
LJUBIJANA Classification  
Squamous Intraepithelial Lesion 
(SIL) 
Squamous Intraepithelial 
Neoplasia (SIN) 
2005 WHO 
Classification 
Squamous (simple) hyperplasia Not applicable Squamous cell hyperplasia 
Basal / Parabasal cell hyperplasia SIN 1 Mild hyperplasia 
Atypical hyperplasia SIN 2 Moderate hyperplasia 
Atypical hyperplasia SIN 3 Severe hyperplasia 
Carcinoma in situ SIN3 Carcinoma in situ 
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1.ACTINIC CHEILITIS (SAILOR’S LIP; SOLAR CHEILITIS) 
This lesion is a form of actinic keratosis and occurs on the 
lower lip. It is directly related to prolonged exposure to sun and is 
common with ultraviolet B (UVB) irradiation at 290 – 320 nm. It is most 
common in white males and in fourth decade. The vermilion of the lip 
appears pale and atrophic with a glossy surface, sometimes with 
wrinkling and fissuring. Demarcation at the vermilion border is usually 
lost. Later on, as the lesion progresses, there is fissuring and ulceration, 
sometimes with crusting or scaling.  
Microscopic features include epithelial atrophy, 
hyperkeratosis and elastosis of the submucosa with lymphocytic 
infiltration. These changes turn to be irreversible. Risk of malignant 
transformation is 6 – 10%.Treatment consists of prophylactic laser 
ablation or vermillionectomy. These patients are also at high risk for 
other cancers related to sun exposure, and hence close follow up is 
essential.81-2 
2.LEUKOPLAKIA: 
 The term leukoplakia means “white patch,” in Greek. World 
Health Organization defines leukoplakia as a white patch, not less than 5 
mm, that cannot be rubbed off easily or clinically identified as another 
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named entity.  Leukoplakia frequently presents over the age of 40 and is 
common in men. But due to the change in trend with regard to smoking, 
leukoplakia is on increasing scene in women nowadays. The common 
etiopathogenesis is related to the use of tobacco in smoked or smokeless 
forms. Also related etiological factors are alcoholism, infection by 
Candida albicans , trauma  and the last but one is the nutritional 
deficiency , particularly iron deficiency anaemia leading to sideropenic 
dysphagia named by the syndrome Plummer Vinson or Paterson Kelly 
syndrome.  Mostly these lesions are benign. The common sites are ventral 
or lateral tongue and floor of mouth in the past decades which has now 
switched over to buccal mucosa and mandibular mucosa amounting for 
atleast half the cases. Less common to involve are the palate, lip and floor 
of mouth.  
Clinically, it is aymptomatic with variable presentation and 
appearance in regard to size, shape, colour and thickness. The common 
presentation varies from a relative whiteness on a normal appearing non 
inflamed mucosa to a well defined white, leathery, thickened , fissured or 
warty growth. Palpation of the lesion exhibits a soft, smooth consistency 
to a nodular or indurated lesion. On clinical grounds, leukoplakia is 
further classified into four types, viz homogenous, non homogenous, 
proliferative verrucous leukoplakia and erythroplakia. Homogenous 
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leukoplakia consists of more or less well demarcated uniform white 
plaque with or without fissuring. Non homogenous variant includes 
erythroleukoplakia, speckled and nodular types. These lesions have more 
risk of dysplasia or carcinoma. Erythroleukoplakia is a red and white 
lesion with fissures and usually well demarcated. This lesion needs to be 
differentiated from lichen planus, which show more typical reticulations.   
However, around 9 to 47% of leukoplakia seems to exhibit 
malignant transformation with features of dysplasia or frank carcinoma 
and this tendency varies with the site of the lesion. About 16 – 36% of 
dysplastic lesions have chance of transforming into frank malignancy. 
Around 16% of benign lesions without dysplasia will turn to dysplasia or 
malignancy. Though leukoplakia in the floor of mouth is seen only in few 
cases, it is more prone for dysplastic changes and carcinoma. Similarly 
tongue, lip and soft palate also show high degree of malignant 
transformation. Clinically the mimics of leukoplakia include candidiasis, 
lichen planus, white spongy naevus and leukoedema.  
Histologic changes vary from hyperkeratosis, carcinoma in 
situ to invasive squamous cell carcinoma. Leukoplakia shows 
hyperkeratosis, parakeratosis and acanthosis with hyperplastic squamous 
epithelium. Lichenoid changes are seen with chronic inflammatory 
infiltration predominantly of lymphocytes in the submucosa. Dysplasia is 
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noted in thick fissured leukoplakia with loss of maturation and cytologic 
atypia and these changes may also be seen in ducts of minor salivary 
glands present at that site. Most of the lesion has coexistent infection with 
Candida albicans. Verrucous or nodular leukoplakia show verrucous 
epithelial hyperplasia with bulbous rete ridges, mild to moderate 
dysplasia and band like lymphocytic infiltration. Erythroleukoplakia 
shows variable hyperkeratosis, epithelial atrophy, bulbous rete ridges 
with mild to severe degree of dysplasia and band like lymphocytic 
infiltration.83-6 
PROLIFERATIVE VERRUCOUS LEUKOPLAKIA 
Proliferative verrucous leukoplakia (PVL) is a rare still 
specific type of leukoplakia, which is more prone for malignant 
transformation. This lesion frequently occurs in women than in men and 
are common in fifth to sixth decade. It usually presents as flat lesion in 
early stages which later turns to be thick and exophytic. The common 
sites differ from the conventional leukoplakia and are seen in buccal 
mucosa and gingiva. The etiology is unknown and relation with tobacco 
and human papilloma virus are yet been established. The lesion can be 
multifocal and persistent with high rate of recurrence. The commonest 
malignant change is of squamous cell carcinoma and verrucous 
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carcinoma. About 60 – 100% of them have chance of developing into 
dysplasia or carcinoma. 87 
3.ERYTHROPLAKIA: 
The literal meaning of erythroplakia is ‘flat red area’, in 
Greek. Clinically erythroplakia presents as a bright red, velvety patch 
with well defined margins and are usually asymptomatic. Erythroplakia is 
less common than leukoplakia, but with higher degree of risk for 
malignancy. The common causative agents are tobacco, alcohol and 
nutritional deficiency. The common sites of predilection are tongue, floor 
of mouth and retromolar mucosa. Erythroplakia commonly presents in 
fifth to seventh decade and is equally distributed in both sexes.  
The histologic features show decrease in keratin formation 
with increase in vascularity imparting red colour to the lesion. They also 
show dysplastic changes, carcinoma in situ or frank malignant changes. 
Risk of malignant transformation is about 40 – 50%.  Surgical excision is 
the treatment of choice. Wide local excision with adequate margin 
clearance is essential since invasion into adjacent epithelium is noted. 
Hence follow up is essential. Differential diagnosis includes Kaposi’s 
sarcoma, vascular malformation, contact allergic reaction, ecchymosis 
and psoriasis. 88       
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4.TOBACCO POUCH KERATOSIS: 
Tobacco pouch keratosis, also known as snuff dipper’s 
keratosis, is a specific form of leukoplakia. This lesion is more frequently 
related to smokeless tobacco. It results from the direct effect of tobacco 
on the oral mucosa, with predilection for the sites of contact, being the 
mandibular anterior labial vestibule and the posterior buccal vestibule. 
The clinical presentation is gray to whitish mucosa with wrinkled 
appearance and associated pouch-like depression probably due to 
stretching of the tissue with tobacco quid. As the lesion progresses, the 
intensity of white colour is increased still more and it becomes leathery 
and nodular. Adjacent to the lesion, the surrounding gingiva becomes 
inflamed and retracted. This lesion tends to have relatively lower risk of 
malignant transformation, as it resolves on cessation of tobacco. Any 
persistence of ulcer or erythema after discontinuing the tobacco use must 
be followed up with biopsy and evaluated for malignancy. 62,89 
5.ORAL SUBMUCOUS FIBROSIS: 
This lesion is common in many parts of the world with 
incidence of about 4 per 1000 adults in India. Because of increase in use 
of pan masala among young adults, around 5 million Indian youth are 
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getting affected. This lesion is characterized by fibroelastic 
transformation of the adjacent epithelial tissues resulting in mucosal 
stiffening and rigidity. Later it leads to fibrotic bands in the buccal 
mucosa and soft palate leading to difficulty in opening the mouth. The 
main etiologic factor is betal quid consisting predominantly of areca nut 
and tobacco. Additional factors include nutritional deficiency and genetic 
susceptibility. OSF is usually a progressive condition and is irreversible. 
 Histopathologic features include chronic inflammation in 
the subepithelial connective tissue consisting predominantly of 
eosinophils. As the disease progresses, there is decrease in inflammatory 
cells and vascularity, and increase in  infiltration with abundant collagen 
bundles.  Submucosal extension of the lesion manifests as thick band of 
hyalinized collagen bundles in the subepithelial tissue with replacement 
of fat. Moreover, similar picture is also noted in the minor salivary glands 
in the quid exposed area, demonstrating features of chronic inflammation 
and hyalinized fibrosis of the acinar structures. The overlying epithelium 
is atrophic. There is increased risk for malignant change accounting for 4 
– 13% demonstrating epithelial dysplasia. Treatment includes local 
infiltration of steroids and lysis of the surgical bands. But, ultimately 
cessation of tobacco or betal quid usage is the only way to prevent 
progression to carcinoma, though this may not alter the fibrosis.68,90-1 
41 
 
7. ORAL LICHEN PLANUS: 
Lichen Planus is a mucocutaneous disorder of idiopathic 
etiology. It commonly occurs in adults with no gender predilection. This 
lesion is probably immunologically mediated. The common 
manifestation is bilateral white patch. Many variants exist including 
reticular, erosive, papular, plaque and erythematosus forms. Reticular 
form is more common presenting with the characteristic Wickham’s 
striae which are nothing but white keratotic lines in a lacy pattern. It is 
frequently seen in buccal mucosa.  
The plaque variant mimics leukoplakia presenting in the 
buccal mucosa and dorsum of tongue. The erosive or ulcerative form 
manifests as fibrinous plaque with central ulceration. The erythematous 
variant is an atrophic form with reddish patch and fine white striae. 
Microscopic features consists of hyperkeratosis, vacuolization in the 
basal layer with keratinocytes and saw tooth rete ridges . 
Lymphophagocytic reaction mainly band like lymphocytic infiltration is 
seen at the junction between epithelium and connective tissue. The 
characteristic are the Civette bodies, which are eosinophilic ovoid bodies 
in the basal layer. Also, many Langerhans cells are seen in the 
epidermis. The risk of malignant transformation is minimal with 0.4 – 
2.5% , mostly with erosive form of lichen planus.70,85 
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DYSPLASIA: 
  Dysplasia refers to abnormal epithelium and disordered 
growth. Dysplasia is graded into three histologic types and is designated 
as mild, moderate, and severe dysplasia. The microscopic features of 
dysplasia are as follows 
I. ARCHITECTURAL DISTURBANCE: 
(1) Irregular stratification 
(2) Basal cell crowding with loss of polarity 
(3) Drop-shaped epithelial ridges 
(4)  Premature keratinization in single cells 
(5) Reduced intercellular adhesion 
(6) Keratin pearls within rete ridges 
(7) Increased mitotic figures 
(8)  Abnormal superficial mitosis 
II. CYTOLOGIC ATYPIA 
1. Nuclear pleomorphism and hyperchromatism 
2. Anisonucleosis 
3. Increased nuclear size 
4. Anisocytosis and cellular pleomorphism 
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5.  Increased nucleus to cytoplasmic ratio 
6. Abnormal mitotic figures 
7. Increased number and size of nucleoli 
 
Mild dysplasia 
Mild dysplasia is defined as the architectural disturbance 
limited to the lower third of the epithelium with associated cytological 
atypia. It is characterized by basal zone hyperplasia with mild increase in 
thickness. Cellular crowding is seen only in the lower one third of the 
epithelium and mitosis is absent. Nuclei show mild degree of 
pleomorphism. 
Moderate dysplasia 
Moderate dysplasia relates to architectural disturbance 
extending into the middle third of the epithelium. Anyhow, it is upgraded 
in view of increased cytologic atypia. There is moderate increase in 
thickness with basal zone hyperplasia. Cellular crowding involves the 
lower two thirds of the epithelium with no loss of polarity. Nuclear 
grooves and lobulations may be seen with moderate degree of cellular 
and nuclear pleomorphism. Mitosis is appreciated in the lower one third. 
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Severe dysplasia 
Severe dysplasia involves architectural irregularity and 
increased cytologic atypia in more than two thirds of the epithelium. 
Markedly increased thickness with basal zone expansion is noted. There 
is loss of polarity with mitosis in the lower two thirds of the epithelium. 
Cells demonstrate high nuclear cytoplasmic ratio, nuclear folding, coarse 
chromatin and prominent nucleoli with increased pleomorphism. 
CARCINOMA IN SITU: 
                Carcinoma in situ is defined as architectural irregularity and 
increased cytologic atypia involving full thickness of the epithelium, but 
invasion is absent. There is epithelial disarray with cellular crowding, 
loss of polarity and full thickness atypia. Marked degree of cellular and 
nuclear pleomorphism is noted and mitotic figures are seen throughout 
the epithelium. No flattening of surface layer is seen. The basement 
membrane is intact, but may have thinning when seen with 
immunostains. 80,92 
SQUAMOUS CELL CARCINOMA: 
Squamous cell carcinoma is the most common malignancy 
of the oral cavity. Almost 90% of the oral tumours come under this 
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category. In India, tumours tend to arise in the vicinity of leukoplakia, 
whereas in western countries, red lesion or normal epithelium is much 
more common. SCC is characterized by lobules of squamous cells with 
cytologic pleomorphism and abundant keratinization.  The malignant 
epithelial cells proliferate and invade the stroma singly or as islands or 
cords. There is increase in nuclear cytolopasmic ratio with increased 
apoptotic bodies. Mitosis is increased with many abnormal mitotic 
figures. Variable amounts of desmoplasia and inflammatory infiltration 
with lymphocytes and eosinophils are seen. Perineural and vascular 
invasion is noted. The adjacent epithelium shows dysplastic changes or 
features of carcinoma in situ. 
Squamous cell carcinoma is graded based on the degree of 
differentiation of the epithelium, nuclear pleomorphism and mitotic 
activity. SCC is usually graded into three categories viz., well 
differentiated, moderately differentiated and poorly differentiated grade. 
Well differentiated SCC: 
 In this type, the tumour resembles normal squamous 
epithelium and consists of large differentiated keratinocyte like 
squamous cells with the periphery of the tumour having small basal type 
cells. Keratinisation is present throughout. The characteristic is the 
presence of intercellular bridges. Only few mitoses are noted. 
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Moderately differentiated SCC: 
In this type of SCC, there is increase in nuclear 
pleomorphism and keratinization is reduced. Mitosis is increased with 
many abnormal mitotic figures. 
Poorly differentiated SCC: 
  Here the basal type cells predominate. Mitoses are numerous 
with increased abnormal mitotic figures. The intercellular bridges are 
barely recognized and keratinization is usually minimal.68,70,72,80,92 
VARIANTS OF SQUAMOUS CELL CARCINOMA 
There are many variants of squamous cell carcinoma. It is 
important to distinguish them as they differ in their prognosis. Only few 
tumours present entirely of their classical features. Most of them occur in 
combination with conventional SCC presenting as mixed tumours. 
However, it is better to mention the histological variation, which would 
be possible for the clinician to delineate the tumours with aggressive 
behavior or poor prognosis. 
VERRUCOUS CARCINOMA: 
About 5% of the oral carcinomas belong to this category. 
Initially this term was first used to describe a large exophytic , warty, 
acanthotic lesion with mild cytologic atypia.  Friedell and Rosenthal in 
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1941 was the first to demonstrate verrucous carcinoma of oral cavity, 
which was later well established by Ackerman in 1948 as a non 
metastazing, but locally invasive SCC. This is commonly seen in men 
over the age of 70 years. Verrucous carcinoma has predilection for 
buccal mucosa, alveolar ridge and mandibular sulcus with occurrence in 
other sites like gingiva, tongue, soft palate and tonsillar fossa. This 
tumour has strong association with tobacco in both smokers and  
smokeless tobacco users. The clinical manifestation is that of an 
exophytic growth with warty or papillary surface.  
The histologic features are the epithelium showing marked 
acanthosis, marked parakeratosis and hyperkeratosis. There is papillary 
exophytic and endophytic proliferation of well differentiated squamous 
epithelium. The bulbous frond like rete ridges push downward into the 
submucosa with parakeratin plugging. Only minimal cytologic atypia is 
noted. Lamina propria consists of chronic inflammatory cell infiltration 
with lymphocytes and subbasal clefting. The prognosis is comparatively 
better. 92-98  
BASALOID SQUAMOUS CELL CARCINOMA: 
This is a rare variant of squamous cell carcinoma. Basaloid 
Squamous cell carcinoma was first described by Wain et al in 1986. The 
common sites involved intraorally are tonsils and base of tongue. BSCC 
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has a high male to female sex ratio, predominant in smokers and 
alcoholics and are common over the age of 60 years. BSCC in oral cavity 
seems to be associated with HPV 16.  It is a highly aggressive tumour , 
mostly presenting in Stage III or IV with regional metastasis.     
Microscopically, BSCC is classically arranged in nests, 
lobules and cribriform pattern with basaloid cells having squamous 
differentiation in the nests. The cells are small, with scant cytoplasm, 
indistinct cell borders and dark nuclei exhibiting pleomorphism. Mitotic 
activity is increased. Admixed with them are larger cells having abundant 
cytoplasm, vesicular nuclei with small nucleoli. Nuclear palisading may 
be seen in the periphery of the nests. The characteristic is the presence of 
necrosis with both single cell and comedonecrosis. Some of them may 
have pseudoglandular pattern filled with hyaline or mucoid material 
which is PAS or Alcian blue positive. The stroma may be hyalinized or 
myxoid . BSCC is frequently seen in combination with conventional SCC 
and squamous CIS. BSCC has to be differentiated from basaloid lesions 
like salivary duct carcinoma, solid variant of adenoid cystic carcinoma 
and peripheral ameloblastoma. BSCC commonly metastasize to the lungs. 
The three year survival rate is only 35%.94-7,99 
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PAPILLARY SQUAMOUS CELL CARCINOMA: 
Papillary carcinoma is commonly seen in larynx and 
hypopharynx, but is uncommon in the oral cavity. This presents as an 
exophytic, cauliflower like mass with broad base or as finger like 
papillary projections with slender fibrovascular core. Microscopically it 
consists of non keratinizing epithelial proliferation in papillary exophytic 
or endophytic pattern with considerable cytological atypia, 
paraorthokeratosis and often microabscess at the tips of bulbous rete 
ridges. Hyperkeratosis is minimal and stromal invasion is not well 
defined.  
Depending on the maturation of the overlying epithelium, 
two patterns of proliferations are identified.  One type is undifferentiated 
variant with close resemblance to small cell CIS, and consists of non 
keratinizing basal and parabasal like cells with dysplastic features. The 
proliferation is seen in the entire thickness of the epithelium. This variant 
is frequently seen in tonsils and oropharynx. The next variant comprises 
of varying degrees of keratinization with dysplastic changes in the 
epithelium. PSCC should be differentiated from verrucous carcinoma, 
exophytic conventional SCC and squamous papilloma. The prognosis is 
only 44% and most of them die within 2 years. 95-7,100 
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SPINDLE CELL (SARCOMATOID) CARCINOMA:  
Spindle cell squamous carcinoma is commonly seen in the 
head and neck region, but is rare in the intraoral site, presenting in the 
tongue, lower lip, gingiva and alveolar ridge. Spindle Cell Carcinoma is 
common among males in their sixties. The tumour presents as red lesions,  
non healing ulcer associated with pain or as exophytic bosselated mass . 
The etiological factors include tobacco use, previous radiation, poor oral 
hygiene and alcohol abuse. It is a spindle cell tumour and consists 
predominantly of sheets of spindled pleomorphic cells. This tumour may 
resemble malignant fibrous histiocytoma and hence needs to be 
differentiated from other soft tissue sarcomas. However, the spindle cell 
component is admixed with conventional squamous cell carcinomatous 
areas. The metastatic deposits of the sarcomatoid carcinoma show pure 
carcinomatous or mixed components in lymph node and distant              
sites. 95-7,101 
ADENOID / ACANTHOLYTIC SQUAMOUS CELL CARCINOMA 
In this variant, the tumour show pseudoglandular or alveolar 
architecture. This tumour is more common in men. The usual site 
involved is the lip, but also seen in tongue and gingiva.  The main 
etiological factor is irradiation. The tumour is arranged in biphasic pattern 
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with proliferation of malignant  epithelial cells associated with 
acantholysis and formation of  pseudoglandular structures. Here, there is 
loss of intercellular adhesion within the tumor cell nests creating a 
glandular pattern. The tumour is more aggressive with  poor      
prognosis. 95-7,102 
ADENOSQUAMOUS CARCINOMA: 
This is a rare tumour which exhibits both squamous and 
glandular differentiation. The glandular differentiation is thought to have 
arisen from minor salivary glands. The involvement of the salivary gland 
ducts in these tumors support the hypothesis, but is still controversial. 
The currently favoured explanation is the derivation from surface 
epithelium. The main etiological factor is proposed to be tobacco and 
alcohol use, but is not confirmed. The sites involved are floor of mouth, 
tongue, tonsil, palate and larynx. This tumour is common in males in their 
sixties.   
The tumour is biphasic with proliferation of malignant 
squamous and basaloid epithelial cells admixed with duct like structures 
having mucous cells. This neoplasm has to be differentiated from 
mucoepidermoid carcinoma and conventional SCC invading the normal 
salivary gland. These tumors have an aggressive course with poor 
prognosis. There is increased tendency for local recurrence (45%) and 
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early nodal metastasis (65%). The five year survival rate is 13% and at 10 
years it is only 4.5%. The presenting feature is erythroplakia with ulcer or 
submucosal nodule. 
Microscopically adenosquamous carcinoma is characterized 
by three distinct components a) squamous cell carcinoma b) 
adenocarcinoma c) admixture of glandular mucous cells with squamoid 
differentiation which resemble mucoepidermoid carcinoma. Many 
densely keratinized glassy cells are seen. Adjacent areas show foci of 
dysplasia or carcinoma in situ. There is widespread and extensive 
permeation into adjacent soft tissues. Perineural invasion is also       
noted. 95-7,103 
SMALL CELL CARCINOMA: 
Small cell carcinoma has histologic features akin to lung 
carcinoma. This is an aggressive tumour. The tumour consists purely of 
small cells or has an admixture of squamous component.  Few of them 
have Merkel cell carcinoma features.94-7,104 
LYMPHOEPITHELIOMA LIKE CARCINOMA: 
This is a rare tumour of oral cavity. The appearance is 
similar to that of the tumour found elsewhere in head and neck like 
nasopharynx and tonsil.80,95,105 
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CLEAR CELL CARCINOMA:  
                    This is a rare variant of squamous cell carcinoma.95,106 
NUT (MIDLINE) CARCINOMA: 
This is a newly recognized type involving midline structures, 
mainly in the head and neck region. This is frequently seen in children 
and young adults, but affects all age groups. It is characterized by 
rearrangement of the NUT gene on chromosome 15q14. The tumour 
consists of dual population of cells composed of islands of 
undifferentiated cells and islands of keratinization.  There is a sharp 
distinction between these two regions. The diagnosis is confirmed 
immunohistochemically by nuclear expression of NUT in 
undifferentiated cells. NUT carcinoma has an aggressive course, but a 
very good response to chemotherapy. 80,95 
CUNICULATE CARCINOMA: 
This is a rare variant seen commonly on plantar aspect of 
foot and skin lesions. In oral cavity, this lesion is seen in gingiva and 
alveolar ridge and most of them have intraosseous extension.  It has an 
indolent course. Histologically, the tumour is characterized by 
proliferation of stratified squamous epithelial cells in trabecular or ribbon 
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like pattern with complex arborizing architecture and variable cytologic 
atypia. Many convoluted irregular cysts or crypts filled with keratin 
which may burrow into bone are noted. Obvious cytological malignant 
features are not seen. This tumour has to be differentiated from verrucous 
carcinoma. They usually do not metastasize. 80,107 
IMMUNOHISTOCHEMISTRY: 
Premalignant lesions: 
Keratosis without dysplasia : show keratin 19, epidermal growth factor 
and Ki-67 expression limited to basal layer. 
Keratosis with dysplasia : show keratin 19, epidermal growth factor, 
p16INK4A and Ki-67 expression extending to suprabasal cells. 
  Ki-67 is the most important marker helpful in identification and 
grading of dysplasia in premalignant lesions. Few cases of dysplasia 
show p53 overexpression. 
Squamous cell carcinoma: 
Cytokeratin : CK5/6, CK8, and CK19 positive, but are CK20 negative 
●Overexpression of  TP53 oncogene is seen in 30% to 50% cases. 
Basaloid squamous cell carcinoma show immunoreactivity for high 
molecular weight keratin (detected with the 34ßE12 antibody)  
Adenosquamous carcinoma show positivity for CEA, CAM 5.2 
and CK7.80,95-7 
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CANCER STAGING: 
Squamous cell carcinoma is graded according to TNM 
staging of tumours by AJCC. The tumour staging is of important 
prognostic significance and aids in treating the patient. 
2002 AJCC Staging Guidelines for Tumors of the Oral Cavity 
PRIMARY TUMOR (T) 
Primary tumor cannot be assessed (TX) 
No evidence of primary tumor (T0) 
Carcinoma in situ (Tis) 
Tumor ≤ 2 cm in greatest dimension (T1) 
Tumor > 2 cm but not > 4 cm in greatest dimension (T2) 
Tumor > 4 cm in greatest dimension (T3) 
Tumor invades adjacent structures (i.e., through cortical bone, into deep [extrinsic] 
muscle of tongue [genioglossus, hyoglossus, palatoglossus, and styloglossus], 
maxillary sinus, skin of face) (T4a) 
Tumor invades masticator space, pterygoid plates, or skull base and/or encases 
internal carotid artery (T4b) 
(Lip) Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, 
or skin of face, i.e., chin or nose (T4) 
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REGIONAL LYMPH NODES (N) 
Regional lymph nodes cannot be assessed (NX) 
No regional lymph node metastasis (N0) 
Metastasis in a single ipsilateral lymph node, ≤ 3 cm in greatest dimension (N1) 
Metastasis in a single ipsilateral lymph node, > 3 cm but not > 6 cm in greatest 
dimension (N2a) 
Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest    
dimension (N2b) 
Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest 
dimension (N2c) 
Metastasis in a lymph node > 6 cm in greatest dimension (N3) 
DISTANT METASTASIS (M) 
Distant metastasis cannot be assessed (MX) 
No distant metastasis (M0) 
Distant metastases (M1) 
STAGE GROUPING 
The overall pathologic AJCC stage is 
   Tis/N0/M0 (Stage 0) 
   T1/N0/M0 (Stage I) 
   T2/N0/M0 (Stage II) 
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   T3/N0/M0 (Stage III) 
   T1/N1/M0 (Stage III) 
   T2/N1/M0 (Stage III) 
   T3/N1/M0 (Stage III) 
   T4a/N0/M0 (Stage IVA) 
   T4a/N1/M0 (Stage IVA) 
   T1/N2/M0 (Stage IVA) 
   T2/N2/M0 (Stage IVA) 
   T3/N2/M0 (Stage IVA) 
   T4a/N2/M0 (Stage IVA) 
   T4b/Any N/M0 (Stage IVB) 
   Any T/N3/M0 (Stage IVB) 
   Any T/Any N/M1(Stage IVC)80,108 
 
PROGNOSIS:  
    The most important prognostic indicators of oral cancers are as follows 
1. Location: The overall five year survival rates vary depending upon the 
site of tumour. Lip has a good prognosis with 90% survival rate for 
tumors of lower lip. Next is the anterior tongue with 60% survival rate 
and floor of the mouth, posterior tongue, tonsil, hard palate and gingiva 
having 40%. The poor prognostic tumors are those in the soft palate with 
only 20- 30% survival rate. 
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2. Tumour stage:  This is the most important prognostic index. The five 
year survival rates without recurrence for various stages are as follows : 
stage I - 91%, stage II - 77.2%, stage III - 61.2%, stage IV A - 32.4% , 
stage IV B - 25.3% and for stage IV C -3.6% 
3. Grade: This is a separate prognostic marker. The grading of deep 
invasive margins in a tumour proves to be more useful than that of entire 
tumour. 
4.  Tumour size: It has nothing to do with prognosis except for small 
neoplasms. 
5. Depth of invasion: This play a role in grading at selected sites. Tumour 
thickness correlates well with recurrence, lymphnode metastasis and 
survival rate.  
Tumour < 3 mm has 8% subclinical metastasis, no recurrence and good 
survival rate. Tumour > 9 mm has 53% metastasis with recurrence 24% 
and a 5 year survival rate of 66%. 
6. Tissue eosinophilia: Dense infiltration of eosinophils in the tumour is a 
better prognostic factor. 
7. Desmoplasia: In squamous cell carcinoma of lip, presence of abundant 
desmoplastic reaction is considered as worse prognosis with increased 
chance of metastasis. 
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8. Lymph node metastasis: This is an important factor in staging and 
hence of worst prognosis. The prognosis still more decrease with 
extracapsular spread. 
9. DNA ploidy: DNA ploidy has much correlation with microscopic 
grading. Most of the oral cancers are polyploid or aneuploid. The 
nondiploid tumors have worse prognosis compared with that of diploid 
tumours. 
10. HPV status: This is considered as an independent and most significant 
prognostic implicator. The tumors associated with HPV expression have 
better prognosis. 
11. P21 expression: P21 overexpression is considered as worst prognostic 
factor in squamous cell carcinoma of tongue. 
12. P16: p16 expression is found to be a good prognostic indicator. The 5 
year survival rate is 80% for p16 positive cases and 40 – 50% for 
negative cases. 
13. H antigen: Loss of expression of H blood group antigen is found to 
have more chance of invasion and distant metastasis. 
14. TROP2: TROP2 is human trophoblast cell surface antigen, whose 
overexpression decreases the survival rate. 
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15. 3q26.3 locus: This genetic locus amplification causes progression of 
tumour and decreased survival rate.80,94-7 
TREATMENT:  
                     The main stay of treatment for oral carcinoma is surgery and 
radiation therapy, which are used either alone or in combination. Surgery 
and irradiation hold good in early stage lesions. More advanced cases are 
treated with a combination of radiotherapy and chemotherapy. Tumours 
without TP53 expression respond well to radiation due to the high 
proliferation index compared to those with TP53 expression and low    
Ki-67 index.62,95-6 
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MATERIALS AND METHODS 
 This is a case control study carried over a period of 1 year from 
July 2013 to July 2014.  
 The study was conducted on patients of Coimbatore Medical 
College. 
 The age of the patients range from 20 to 65 years. 
 They are randomly selected  from Dental , ENT and Surgical 
Oncology OPD 
 The study sample consists of 80 subjects and is divided into four 
groups as follows: 
Group 1: Control group consists of 20 healthy subjects, who are non 
tobacco users, with clinically normal oral mucosa . 
Group 2: Consists of 20 healthy subjects, who are tobacco chewers, with 
clinically normal oral mucosa. 
Group 3: Consists of 20 subjects, who are tobacco chewers, with oral 
premalignant lesions.  
Group 4: Consists of  20 subjects, who are tobacco chewers, with oral 
malignant lesions.  
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Exclusion criteria:  
            1. Smokers 
            2. Alcoholics 
            3. Patients undergoing radiotherapy in head and neck 
region. 
            4. Patients previously diagnosed and on treatment for oral 
premalignant and malignant lesions.  
                     5. Patients with cancer other than in oral cavity.  
Sample Collection: 
Oral exfoliative cytology is used for mass screening. The 
sensitivity is about 94% and specificity of 100%. Exfoliative cytology of 
buccal cells is collected by various methods like wooden tongue 
depressor, toothpicks, metal spatula, toothbrushes and cytobrush.   
Before sample collection, written and informed consent is 
obtained from the patient. The patient is enquired about the lifestyle 
habits including smoking, alcohol and tobacco habits, duration of the 
habits, frequency of usage, any complaints, investigations taken and 
finally about treatment and medication details.                                 
Immediately before cell collection, the participants are 
instructed to rinse their mouth twice with tap water. Subsequently, the 
cells are scraped with wooden spatulas from each cheek, smeared on 
precleaned slides and smears are fixed with 95% isopropyl alcohol. 
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Staining Procedures:  
  A variety of stains have been employed in assessment 
of micronuclei. Some of them are Fuelgen, acridine orange, DAPI ( 4’,6 –
diaminido-2-phenylindole), Papanicolaou, May Grunwald Giemsa, 
Giemsa, Crystal violet and propidium iodide stains. In this study, the 
smears are separately stained with Papanicolaou, Giemsa and Crystal 
violet stains. 
 
REAGENTS REQUIRED: 
                           1. OG 6 
                           2. EA-36                                             Papanicolaou stain 
                           3. Harri’s Haematoxylin 
                           4. Giemsa solution 
                           5. Crystal violet powder 
 
                      The procedures involved in the different staining 
techniques are as follows 
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PAPANICOLAOU’S STAINING METHOD: 
FIXATION 
 95% Isopropyl Alcohol  - 30 min 
PROCEDURE 
1. Place in 80%   Alcohol   – 1 min 
2. Dip in 70%   Alcohol      – 1 min 
3. Dip in 50%   Alcohol      – 1 min     
4. Wash in Tap Water         - 10 min 
5. Immerse in Harri’s Haematoxylin solution  – 5 min   
6. Rinse in tap water gently and briefly 
7. Quick differentiation with 1%  Acid alcohol. 
8. Wash in Tap water (blueing)   -10 min 
9. Dip in 70%  Alcohol         - 5 min 
10. Dip in 90%  Alcohol         - 5 min 
11. Place in OG II Solution    - 2 min ( monochromate solution) 
12.  Dip in 95%  Alcohol       - 1 min 
13.  Dip in 95%  Alcohol         - 1 min      
14.  Dip in 95%  Alcohol         - 1 min         
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15. Place in EA 50 solution    - 4 min ( polychromate solution) 
16. Dip in 95%  Alcohol           - 1 min 
17. Dip in 95%  Alcohol           - 1 min     
18.  Dip in 95%  Alcohol           - 1 min      
19.  Place in Xylene : Alcohol ( 50:50) mixture  – 5 min  
20.  Clear in Xylene                - 10 min 
21.  Mount in DPX                                         
 
  Papanicolaou staining method is named after George 
Papanicolaou and is commonly used in cytopathology. The pap stain 
gives good visualization of the exfoliated epithelial cells. It is a 
polychrome stain which demonstrates variations in cellular morphology 
including cellular maturity and metabolic activity.  
The advantages are differential cytoplasmic counterstaining 
and transparency with well stained nuclear chromatin. The nuclei are 
stained blue, cytoplasm of keratinized squamous cells are orange or pink 
and those of non keratinized cells are stained blue or green.109-11 
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                        GIEMSA STAINING TECHNIQUE 
 FIXATION: 
                  Isopropyl Alcohol   -  30 minutes. 
Preparation of Working Solution: 
            Giemsa Stock solution  -  1 ml 
            Distilled water               - 9 ml        ( 1: 9 ratio) 
PROCEDURE: 
1. Wash in distilled water  - 15 dips  
2. Place in Giemsa working solution for 2 hours 
3.  A quick dip in 1% acetic acid 
4. Slides are blotted dry with filter paper 
5. Differentiate with 100% ethyl alcohol until there is only a slight 
bluish tint to alcohol 
6.  Clear in xylene 10 dips – two changes. 
7.  Mount with DPX. 
Giemsa is a Romanowsky polychromatic stain. The cells are 
stained purple in colour. It is one among the commonly used cytological 
stains.109-10 
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                    CRYSTAL VIOLET STAINING METHOD 
FIXATION: 
               Fix in Isopropyl Alcohol  -  30 minutes. 
Preparation of working solution: (1% crystal violet solution) 
                   Crystal violet powder  - 1 gm 
                   Distilled water            - 100 ml  
PROCEDURE:  
1. Stain with 1% crystal violet working solution for 1 minute 
2.  Blot with filter paper  
3. Clear in two changes of xylene  
4.  Mount with DPX medium. 
 Mitotic cells are stained magenta and stand out distinctly against a light 
blue background of resting cells.  
Crystal violet is a basic dye and has more affinity for the 
highly acidic chromatin of mitotic cells. It is used to demonstrate high 
mitotic counts. The major advantage is quick staining method and easy 
identification of mitotic figures at a lower magnification compared to 
H/E-stained section (Ankle et al., 2007).112 
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IDENTIFICATION OF MICRONUCLEUS: 
Many factors influence the assessment of micronuclei which 
are as follows 
            1. Timing and implements used in collection of cells 
            2. Fixation and staining methods 
            3. Selection and number of cells counted 
            4. Scoring criteria adopted 
            5. Associated nuclear anomalies 
            6. Presence of other cellular structures like bacteria and 
keratohyaline globules. 
SCORING CRITERIA: 
                     The criteria for selecting cells with micronuclei as provided 
by Tolbert et al is as follows: 
1. Intact cytoplasm and relatively flat cell position  
2. Little or no overlap with adjacent cells 
3. Little or no debris 
4. Nucleus normal and intact, nuclear perimeter smooth and distinct. 
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                     The recommended criteria for the identification of 
micronucleus is 
1. Rounded smooth perimeter  
2. Less than one third the diameter of the associated nucleus 
3. Staining intensity similar to that of the nucleus 
4. Texture similar to that of nucleus 
5. Same focal plane as nucleus 
6.  Absence of overlap with, or bridge to, the nucleus.25   
 
In this study, cellular evaluation is performed using optic 
microscope with 100X  magnification. 500 cells per smear are counted in 
zigzag method. The presence of micronucleus in all subjects and the 
number of cells showing micronuclei are calculated. The mean number of 
micronuclei in nuclei can also be determined using the following formula 
               The total number of micronuclei in each cell       X  100 
                 The number of cells with micronucleus  
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Statistical analysis: 
   Data obtained was coded and entered into Microsoft excel 
spread sheet (Annexure II). The data was analysed using ratio and 
percentage.  Continuous data was expressed as mean and median. 
Correlation between the micronuclei frequency in the four study 
population was calculated using Annova test. 
  
 
 
 
 
OBSERVATION AND 
RESULTS 
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                                 OBSERVATIONS AND RESULTS  
 
                         The present study was a case control study conducted in 
the Department of Pathology, Coimbatore Medical College Hospital. 
A total of 80 cases of buccal smear were taken over the period from 
July 2013 to July 2014 and cytological examination was done. 
                         Ethical clearance for the study was obtained from the 
Ethics Committee of Coimbatore Medical College, Coimbatore. 
                          The micronuclei frequency in oral exfoliative cytology is 
evaluated in precancerous and cancerous oral conditions in tobacco 
chewers and are compared with that of apparently healthy tobacco 
chewers and normal persons. 
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TABLE 3. INCIDENCE IN DIFFERENT AGE GROUPS. 
 
AGE 
GROUP 
(Age in 
Years) 
MALIGNANCY PREMALIGNANT LESIONS 
HEALTHY 
TOBACCO 
CHEWERS 
CONTROLS
<40 10% 20% 40% 15% 
41-50 20% 35% 30% 25% 
51-60 20% 25% 10% 20% 
61-70 35% 15% 10% 25% 
>70 15% 5% 10% 15% 
 
 In the present study, the incidence of malignant cases seems to be higher 
over the age of 50 years. Comparitively, healthy tobacco chewers and 
premalignant cases are higher in less than 50 years of age. 
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CHART 1: INCIDENCE IN DIFFERENT AGE GROUPS 
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TABLE 4. DIFFERENCE IN GENDER DISTRIBUTION 
 
 MALE % FEMALE % 
MALIGNANCY 7 35% 13 65% 
PREMALIGNANT 
LESIONS 
8 40% 12 60% 
HEALTHY 
TOBACCO 
CHEWERS 
7 35% 13 65% 
CONTROLS 8 40% 12 60% 
 
 
      In the current study, the study population show female 
preponderance. This is probably a selection bias as the three study groups 
are selected on exclusion of smoking, alcoholism and other cancers. The 
male to female ratio is observed to be 1:2. 
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  CHART 2.  DIFFERENCE IN GENDER DISTRIBUTION 
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CHART 3. AGE AND SEX DISTRIBUTION IN VARIOUS STUDY 
GROUPS 
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TABLE 5. INCIDENCE IN VARIOUS SITES OF THE LESIONS 
 
SITE MALIGNANCY Percentage PREMALIGNANT 
LESIONS 
Percentage 
BUCCAL 
MUCOSA 10 50% 12 60% 
TONGUE 6 30% 8 40% 
LIP 1 5%   
FLOOR OF 
MOUTH 1 5%   
HARD 
PALATE 1 5%   
SOFT 
PALATE 1 5%   
 
            In the present study, about half of the malignant and premalignant 
lesions are seen in the buccal mucosa, the commenest site where the quid 
is placed. Next comes the tongue carcinoma with 30% occurrence. Other 
sites like lip, floor of mouth, hard and soft palate each share a single case. 
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CHART 4. DIFFERENCE IN  INCIDENCE OF VARIOUS SITES 
  
 
Buccal 
Mucosa
Tongue
Lip
Floor of 
Mouth
Hard 
Palate
Soft Palate
50%
60%
30%
40%
5%
5%
5%
5%
Incidence in Various Sites Of The Lesions
Buccal Mucosa Tongue Lip Floor of Mouth Hard Palate Soft Palate
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CHART 5.  FREQUENCY OF MN /500 CELLS IN NORMAL 
CONTROLS 
 
 
Table 6 : One-Sample Statistics for Normal Controls (n = 20) 
 
N Mean Std. Deviation Std. Error Mean
PAP 20 3.40 .995 .222 
GIEMSA 20 2.95 .945 .211 
CRYSTAL        
VIOLET 20 3.00 1.214 .271 
 
        The mean number of micronuclei observed in the controls and the 
difference in the three staining methods are shown in the above table. 
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CHART 6.  FREQUENCY OF MN /500 CELLS  IN HEALTHY 
TOBACCO CHEWERS 
 
 
Table 7 : One-Sample Statistics for Healthy Tobacco Chewers (n=20)  
 N Mean Std. Deviation Std. Error Mean 
PAP 20 12.60 2.280 .510 
GIEMSA 20 11.10 2.447 .547 
CRYSTAL 
VIOLET 
20 13.15 2.540 .568 
  
                           The mean number of micronuclei observed in the 
tobacco chewers with normal oral mucosa and the difference in the three 
staining methods are shown in the above table. 
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CHART  7.  FREQUENCY OF MN /500 CELLS IN  
PREMALIGNANT LESIONS 
 
     
 
 Table 8 : One-Sample Statistics for Premalignant Lesions (n = 20) 
 N Mean Std. Deviation Std. Error Mean
PAP 20 20.20 2.881 .644 
GIEMSA 20 19.75 3.831 .856 
CRYSTAL 
VIOLET 
20 26.60 3.350 .749 
 
              The mean number of micronuclei observed in tobacco chewers 
with premalignant lesions and the difference in the three staining methods 
are presented in the above table. 
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CHART 8.  FREQUENCY OF MN /500 CELLS IN MALIGNANT 
LESIONS 
 
Table 9 :One-Sample Statistics for Malignant Lesions (n = 20)  
 N Mean Std. Deviation Std. Error Mean
PAP 20 33.75 6.536 1.462 
GIEMSA 20 32.65 6.184 1.383 
CRYSTAL 
VIOLET 
20 35.35 6.862 1.534 
  
                      The mean number of micronuclei observed in tobacco 
chewers with carcinoma and the difference in the three staining methods 
are presented in the above table. 
0
5
10
15
20
25
30
35
40
45
50
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Pap
Giemsa
CV
83 
 
 
TABLE 10 .Comparison of Mn/500cells in Various Study Groups Using 
Different Staining Techniques 
STUDY GROUP PAP GIEMSA 
CRYSTAL 
VIOLET 
Controls 3.40 2.95 3.00 
Healthy tobacco 
chewers 
12.60 11.10 13.15 
Premalignant 20.20 19.75 26.60 
Malignancy 33.75 32.65 35.35 
                 
In the current study, the micronuclei frequency is studied in 
four different populations of malignancy, premalignancy, healthy 
tobacco chewers and controls without tobacco habit. The micronuclei 
frequency is assessed by various staining procedures like papanicolaou, 
Giemsa and crystal violet stains and their staining quality are compared. 
The MN frequency is found to be slightly higher with Pap stain 
compared to Giemsa, and still more higher with crystal violet stain. It is 
observed that there is no significant difference seen in evaluating 
micronuclei in the three staining techniques, as only mild variation in the 
values noted with   p > 0.05. 
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CHART 9. Comparison of MN/500cells in Various Study Groups Using 
Different Staining Techniques 
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TABLE 11.Comparison of Micronuclei in Tobacco Chewers with Normal  
Oral Mucosa, Premalignant Lesions and Malignant Lesions. 
 
Descriptives 
 
 
N Mean 
Std. 
Deviation
Std. Error
95% Confidence Interval 
for Mean 
Minimum Maximum
 Lower 
Bound 
Upper Bound 
HEALTHY 
TOBACCO 
CHEWERS 
20 12.6000 2.28035 .50990 11.5328 13.6672 9.00 17.00 
PREMALIGNANT 
LESIONS 
20 20.2000 2.81163 .62870 18.3841 21.0159 15.00 24.00 
MALIGNANCY 20 33.7500 6.53634 1.46157 30.6909 36.8091 22.00 46.00 
Total 60 22.0167 9.82472 1.26837 19.4787 24.5547 9.00 46.00 
 
 
ANOVA 
 
 Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 4634.233 2 2317.117 124.512 <.001* 
Within Groups 1060.750 57 18.610   
Total 5694.983 59    
 
 
As there is no significant difference in the mean micronuclei in the three 
staining techniques, comparison of MN frequency among the study 
groups is done with Pap stain, which is commonly used in most 
laboratories. 
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CHART 10. Comparison of Micronuclei in Tobacco Chewers with 
Normal Oral Mucosa, Premalignant Lesions and Malignant Lesions. 
 
 
 
INTERPRETATION ANALYSIS:     
From table; we found H1-1: Types of incidence has significant difference 
to the micronuclei counting and decision factors; however, mean of 
micronuclei have significant difference to types of incidence as 
F=124.512, P=<.001*.   Therefore, Hypothesis (H1) is supported; thus H1 
is accepted. From Mean plot we interpret that there is maximum number 
of micronuclei counting in Malignancy and immediately followed by 
Premalignant lesions and healthy tobacco chewers. 
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TABLE 12. Comparison of Micronuclei in Malignant and Premalignant 
lesions with controls  
 
 
 
 
 
 
 
 
N Mean 
Std. 
Deviation
Std. Error
95% Confidence 
Interval for Mean 
Minimum Maximum
 Lower 
Bound 
Upper 
Bound 
NORMAL 
CONTROLS 20 3.4000 .99472 .22243 2.9345 3.8655 2.00 5.00 
PREMALIGNANT 
LESIONS 20 20.2000 2.81163 .62870 18.3841 21.0159 15.00 24.00 
MALIGNANCY 20 33.7500 6.53634 1.46157 30.6909 36.8091 22.00 46.00 
Total 60 18.9500 13.15414 1.69819 15.5519 22.3481 2.00 46.00 
 
ANOVA 
 
 Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 9228.100 2 4614.050 268.163 <.001*
Within Groups 980.750 57 17.206   
Total 10208.850 59    
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CHART 11.Comparison of Micronuclei in Malignant and Premalignant 
lesions with controls  
 
 
 
INTERPRETATION ANALYSIS:     
From table; we found H1-1: Types of incidence has significant difference 
to the micronuclei counting factors; however, mean of micronuclei have 
significant difference to types of incidence as F=268.163, P=<.001*.   
Therefore, Hypothesis (H1) is supported; thus H1 is accepted. From 
Mean plot we interpret that there is maximum no of micronuclei counting 
Malignancy and immediately followed by Premalignant lesions and 
Normal Controls. 
 
 
 
89 
 
TABLE 13.Comparison of Micronuclei in controls and healthy tobacco 
chewers  
 
Descriptives 
 
 
N Mean 
Std. 
Deviation 
Std. 
Error 
95% Confidence 
Interval for Mean 
Minimum Maximum
 Lower 
Bound 
Upper 
Bound 
NORMAL 
CONTROLS 20 3.4000 .99472 .22243 2.9345 3.8655 2.00 5.00 
HEALTHY 
TOBACCO 
CHEWERS 
20 12.6000 2.28035 .50990 11.5328 13.6672 9.00 17.00 
Total 40 8.0000 4.97171 .78610 6.4100 9.5900 2.00 17.00 
 
 
ANOVA 
 
 Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 846.400 1 846.400 273.497 <.001*
Within Groups 117.600 38 3.095   
Total 964.000 39    
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CHART 12.Comparison of Micronuclei in controls and healthy tobacco 
chewers 
 
INTERPRETATION ANALYSIS:     
From table; we found H1-1: Types of incidence has significant difference 
to the micronuclei counting and decision factors; however, mean of 
micronuclei have significant difference to types of incidence as 
F=273.497, P=<.001*.   Therefore, Hypothesis (H1) is supported; thus H1 
is accepted. From Mean plot we interpret that there is maximum number 
of micronuclei counting in healthy tobacco chewers as compared with 
normal controls which is very less. 
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TABLE 14: Multiple comparison of micronuclei in four study groups 
 
 
Descriptives 
 
 
N Mean 
Std. 
Deviation 
Std. Error
95% Confidence 
Interval for Mean 
Minimum Maximum
 Lower 
Bound 
Upper 
Bound 
NORMAL 
CONTROLS 20 3.4000 .99472 .22243 2.9345 3.8655 2.00 5.00 
HEALTHY 
TOBACCO 
CHEWERS 
20 12.6000 2.28035 .50990 11.5328 13.6672 9.00 17.00 
PREMALIGNANT 
LESIONS 20 20.2000 2.81163 .62870 18.3841 21.0159 15.00 24.00 
MALIGNANCY 20 33.7500 6.53634 1.46157 30.6909 36.8091 22.00 46.00 
Total 80 17.3625 11.75299 1.31402 14.7470 19.9780 2.00 46.00 
 
 
ANOVA 
 
 Sum of 
Squares df 
Mean 
Square F Sig. 
Between 
Groups 9832.938 3 3277.646 230.745 <.001*
Within Groups 1079.550 76 14.205   
Total 10912.488 79    
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CHART 13.Multiple comparison of micronuclei in four study groups 
 
INTERPRETATION ANALYSIS:     
From table; we found H1-1: Types of incidence has significant difference 
to the micronuclei counting and decision factors; however, mean of 
micronuclei have significant difference to types of incidence as 
F=230.745, P=<.001*.   Therefore, Hypothesis (H1) is supported; thus H1 
is accepted. From Mean plot we interpret that there is maximum number 
of micronuclei counting in Malignancy and immediately followed by 
Premalignant lesions, healthy tobacco chewers and normal controls. 
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DISCUSSION: 
The annual incidence of oral cancer in India is around 75,000 
to 80,000.  Squamous cell carcinoma is the commonest tumour in the 
oral mucosa accounting for 90% to 95%. Around one third of the cancer 
mortality in India is said to be related to tobacco. Oral exfoliative 
cytology is used for screening cellular alterations in preneoplastic and 
neoplastic oral lesions. Mass screening by cytology has been reported to 
have 96% reliability and 90% accuracy in detecting squamous cell 
carcinoma.  The sensitivity is about 94% and specificity is 100%.  
                    The present study is aimed at evaluating the differences in 
micronuclei frequencies in various study population which includes 
tobacco chewers with premalignant and malignant lesions, with 
apparently normal oral mucosa and controls of non tobacco users. 
                      Tobacco consumption is said to be higher in people with 
low socioeconomic status and illetrates. Education tends to play a major 
role in lifestyle modification to certain extent, that is why the poor, less 
educated population and illetrates become a prey to tobacco induced 
morbidity and mortality. But still tobacco consumption is not far from the 
well educated concern, only the form of consumption varies. Tobacco 
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chewing is common in uneducated, whereas smoking is prevalent in both 
population.56-9 
In the present study, the incidence of oral malignant lesions 
is found to be common after the age of 50 years. The variation in age 
seems to increase from apparently healthy tobacco chewers to 
premalignant lesions to cancerous lesions. The age incidence correlates 
well with most of the studies done in oral cancer.19-22,51 This can be 
disputed that as the frequency and duration of tobacco chewing increases, 
there is significant increase in the complication from healthy oral mucosa 
and premalignant state to malignant transformation.            
According to WHO, the incidence of oral carcinoma is 
higher in males. The ratio of male to female is 3:2. But in the current 
study, the incidence is observed to be higher in females and the ratio is 
reversed. This is probably due to tobacco quid chewing is predominantly 
seen in women and also because of the exclusion of other lifestyle habits 
like smoking and alcohol.55-60 This result is compared well with the study 
conducted by Piyathilake et al. who defend that the micronuclei 
frequencies are 2.8-fold higher in women when adjusted for age, race, 
smoking, alcoholism and nutritional deficiencies.113 
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In the present study, the commonest site of occurrence of 
malignancy is found to be buccal mucosa with 50% incidence. This is the 
favourable site in tobacco chewers since the betal quid is placed here for 
quite a long period which tends to cause chronic irritation. The tongue is 
the next common site to be involved with 30%. Rest of them is 
constituted by floor of mouth, lip, soft and hard palate each accounting 
for 5%. This is in contrast with the incidence of overall oral malignancies 
which ranks tongue malignancy as the frequent site.                                
The mean micronuclei frequency in the four study 
population is analysed and compared using different staining procedures 
commonly used in laboratories including Papanicolaou, Giemsa and 
Crystal violet stains and the results are presented in Table 8.  The mean 
MN frequency show no difference in various staining techniques in all 
the four study population (p > 0.05).   
Grover et al, 2012 studied the mean MN frequency in oral 
cancer cases and compared them with three different stains like Pap, 
Fuelgen and Hand E.  They found MN frequency was significantly higher 
in cases (P < 0.01) than that of controls in each of the three stains.  
Feulgen stain has the least MN frequency, H and E shows the higher 
count, while the Pap stain shows intermediate values. The observation 
was similar in case of controls.114  
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Mala Khamboj and Sumita Mahajan, 2007 had studied 25 
cases of histologically proven leukoplakia and Squamous Cell 
Carcinoma and assessed MN frequency in buccal smears using Fuelgen 
and Acridine Orange (fluorescent) staining methods. They concluded 
that the mean MN frequency showed significant increase in leukoplakia 
and SCC when compared to controls.115 
As there is no significant difference in the mean micronuclei 
in the three staining techniques, comparison of MN frequency among the 
study groups is done with Pap stain. The mean MN is evaluated to be 
3.4, 12.60, 20.20 and 33.75 in healthy controls, healthy tobacco chewers, 
premalignant lesions and malignant lesions respectively. The observed 
results show an overall MN frequency in tobacco chewers with 
malignant lesions is higher (33.75 ± 6.5) when compared to tobacco 
chewers with premalignant lesions (20.20 ± 3.35), healthy tobacco 
chewers (12.60 ± 2.20) and healthy controls (3.4 ± 0.99). The mean 
difference among the different study population is found to be statiscally 
significant (p < 0.001).   The observation in the present study is similar 
to those analysed by the following studies.  
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Casartelli et al. assessed micronuclei frequencies in 
exfoliated buccal cells in premalignant lesions and malignant lesions of 
oral cavity. They contended an increase in micronuclei frequency in order 
from normal mucosa to premalignant lesions to carcinoma.28 
Stich and Rosin, had predicted higher baseline micronuclei 
frequencies in their earlier studies done in 1983 and 1984. But this is 
largely due to lack of definite scoring criteria.19-22 
Abbas et al, Dec 2012 have analysed micronuclei frequency 
in Toombak users ( Toombak – tobacco preparation in Sudan) and found  
higher micronuclei frequency in Toombak users than control group 
indicating the toxic effects of tobacco. The micronuclei frequencies seem 
to raise with increase in the duration and frequency of Toombak use and 
this was found to be statistically significant and p<0.000.116 These 
findings correlate well with the findings of  Ozkul et al. (1997).117 
 Anila et al, 2011 observed significant increase in micronuclei 
in buccal exfoliated cells in betel quid chewers as against healthy 
individuals. The micronuclei frequency was still more higher in smokers 
who are also chewing a mixture of betal nut, tobacco. They illustrated 
MN frequency of 0.5 – 5.74% in oral submucous fibrosis cases and 
proved to be a significant increase compared to the controls.118 
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Pratheepa Sivasankari et al, 2008 evaluated 25 cases of 
chronic tobacco users with premalignant and malignant oral lesions. They 
found similar results in micronuclei frequency.119 
Desai et al. (1996) noted similar results in his study on the 
exfoliated buccal cells of patients with precancerous oral lesions 
including leukoplakia, oral submucous fibrosis, and lichen planus.120 
They predicted an increase in MN frequency in the study group compared 
to the healthy individuals. This also agrees with the findings of Saran et 
al. (2008).121 
                    Ahmad et al. (2006) point out a good correlation of increased 
micronuclei frequency in gutkha users with oral submucous fibrosis. 
They also observed that gutkha chewing induced OSMF in a shorter 
duration of 4years when compared to other causes. This is probably 
explained by various ingredients of the quid and frequency of quids per 
day.122 
  The HUMN project is a valuable tool developed for 
evaluating and assessing the micronuclei in buccal cells. It validates 
various procedures of collecting samples, different staining modalities, 
risk strategies, comparison of MN frequencies in various study population 
and the diagnostic criteria. HUMN validation project speculates the 
variability of MN frequency in human lymphocytes.  Further it implies on 
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the evaluation of more than 1000 epithelial cells to validate micronuclei 
and for better results.51,123 
                    Devendra Palve and Jagdish Tupkari, 2008 had insisted that 
MN frequency as a valuable prognostic marker in oral SCC. They found 
good correlation of histological grades of squamous cell carcinoma and 
micronuclei in increasing proportions. The MN was found to be increased 
than in controls and similarly in increasing grades of the tumour. Here, 
the micronuclei was assessed by Pap stain.124 
                       Veerendra Kumar et al, 2000 had evaluated 86 cases of oral 
squamous cell carcinoma and correlated the micronuclei frequency with 
different grades of SCC. They concluded a good association of 
cytogenetic damage with micronuclei frequency and carcinogenic effects 
of tobacco and paan.125 
                                Halder et al, 2004 had analysed 50 cases of oral 
premalignant and malignant lesions and compared them with healthy 
controls. They observed that MN frequency seem to be increased in 
preoperative patients and tend to decrease postoperatively. Similarly, the  
MN frequency is increased in premalignant lesions than in healthy 
controls.They implied micronuclei frequency as a biomarker of 
carcinogenesis as well as a prognostic indicator.126 
  
 
 
 
 
SUMMARY AND 
CONCLUSION 
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SUMMARY AND CONCLUSION 
Oral carcinoma is one among the top three cancers of the 
country showing an increasing trend for few decades. Squamous cell 
carcinoma, constituting about 90% of the tumour burden, needs to be 
diagnosed and treated at the earliest. So, it has become essential to 
innovate minimally invasive techniques like micronuclei assay in 
diagnostic modalities for primary and secondary prevention in tobacco 
users. The micronuclei assay holds good as an upcoming research tool 
for biomonitoring. 
The present study is a case control study carried over a 
period of one year from July 2013 to July 2014 at Coimbatore Medical 
college  and hospital, Coimbatore. The study population comprises of  
four groups of each 20 cases viz., tobacco chewers with malignancy, 
tobacco chewers with premalignant lesions, apparently healthy tobacco 
chewers and healthy controls without tobacco habit. Exfoliative oral 
cytology was analysed in these groups. 
 The micronuclei frequency of the four groups are studied 
using Pap, Giemsa and crystal violet stains. There is no significant 
difference of MN frequency observed in these staining techniques. 
Though many studies recommend Fuelgen as the optimal staining 
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procedure, this study aims in evaluating cost effective, simple, rapid and 
readily available staining techniques that suit well for mass screening.  
The present study concludes that there is a significant 
difference in the mean micronuclei frequency of the study groups. The 
MN frequency is found to be higher in malignant lesions as compared in 
order with premalignant lesions and healthy tobacco chewers, and 
controls. 
Thus, micronuclei in oral exfoliative cells is a good 
promising domain in detecting cytogenetic damage and aiding in early 
diagnosis, treatment and prognosis. However, the buccal MN assay has to 
be standardized in view of sample collection, staining modalities and 
diagnostic criteria followed. Further, the whole of the smear should be 
screened for obtaining exact MN frequency and preferably at least 1000 
cells should be validated. As this is time consuming and has high chance 
of interobserver variations, MN assay needs to be automated. Many 
studies are being done in the scenario and more valuable improvements 
are expected.  
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ANNEXURE - I 
 
ANNEXURE  I 
PROFORMA 
 
COIMBATORE MEDICAL COLLEGE 
DEPARTMENT OF PATHOLOGY 
COIMBATORE. 
Particulars of the  patient 
Name                :                                                   IP/OP No  : 
Age                  :                                                    Ward No  : 
Sex                   :                                                Occupation  : 
Address            : 
 
Presenting  Complaints : 
H/o oral ulcer or growth – duration 
H/o treatment taken for the growth – radiotherapy/ chemotherapy details 
H/o sharp dentures 
 
Family History : 
  
Personal History : 
• H/o Tobacco habit – Form of tobacco usage 
                                  Frequency of use / day 
                                  Duration of  addiction 
 
• H/o smoking & alcoholism 
• H/o intake of spicy foods 
 General Physical Examination: 
Built/ Nourishment :                                           Febrile / Afebrile : 
Pallor :                                                                 Vital Signs          : 
Jaundice : 
Lymphadenopathy : 
 
Local Examination of Oral Cavity : 
• Ulcer / patch / growth 
• Site of ulcer / growth 
• Dentition – caries / sharp tooth 
 
Clinical Diagnosis : 
Tumour Staging : 
Cytological Examination : 
•  Number of Micronuclei assessed using Pap Stain 
•  Number of Micronuclei assessed using Giemsa Stain 
• Number of Micronuclei assessed using  Crystal Violet 
stain 
 
Histological findings and diagnosis : 
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ANNEXURE – III 
 
ANNEXURE  III 
 ABBREVATIONS TO MASTER CHART 
 
SCC   : Squamous Cell Carcinoma 
WD   : Well Differentiated 
MD   : Moderately Differentiated 
PD    : Poorly Differentiated 
MiD  : Minimal Dysplasia 
MoD : Moderate Dysplasia 
SMF : Submucous Fibrosis 
MN   : Micronuclei 
PAP  : Papanicolaou stain 
CV    : Crystal Violet stain 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
ANNEXURE – IV 
 
                                      ANNEXURE IV  
 
CONSENT FORM  
Dr.R.Suganya, postgraduate student in the Department of Pathology, 
Coimbatore Medical College is conducting a study on “ Role of 
Micronuclei as a diagnostic tool in exfoliative cytology of oral 
preneoplastic and neoplastic conditions among tobacco 
chewers”. The study and test procedures were explained to me clearly. I 
hereby give my consent to participate in this study and to give buccal smear. 
The data obtained herein may be used for research and publication. 
 
Name:                                                     
Age / Sex : 
Address : 
 
 
Place: 
Date :                                                                                   Signature 
 
 

 
  
xg;g[jy; gotk;; [ ; ;; [ ; ;; [ ; ; 
bgah;  : 
taJ  :       ghypdk; : 
Kfthp : 
 
 muR nfhit kUj;Jtf; fy;Y}hpapy; neha; Fwpapay; Jiwapy; 
gl;l nkw;gog;g[ gapYk; khztp kU.u.Rfd;ah mth;fs; nkw;bfhs;Sk; 
“g[ifapiy bky;tjhy; thapy; Vw;glf;Toa g[w;Wneha; kw;Wk; 
g[w;Wnehahf khWk; epiyikfs; nghd;wtw;iw cwpbry;ypapy; \yk; 
fz;lwpa ikf;nuhepa{f;spa!; vd;gJ gad;gLfpwJ” vd;w Ma;tpy; 
nkw;bfhs;Sk; ghpnrhjid gw;wpa bra;Kiw kw;Wk; midj;J 
tptu';fisa[k; nfl;L vdJ re;njf';fis bjspt[gLj;jpf; 
bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
 vdJ thapd; cl;gFjpapypUe;J I!; Fr;rp \yk; thapd; nkw;g[w 
jpRit vLj;J ghpnrhjid bra;tjw;F KGkdJld; rk;kjk; 
bjhptpf;fpnwd;. 
 ,e;j Ma;tpy; vd;Dila midj;J tptu';fs; 
ghJfhf;fg;gLtJld; ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; 
Ml;nrgid ,y;iy vd;gija[k; bjhptpj;Jf; bfhs;fpnwd;. 
,lk; :                 ,g;gof;F 
ehs; :    
        (ifbahg;gk; / nuif)         
